QualityDipStocks / Finance · Brokers & investment banks
StoneX Group SNEX
Outside our quality screen, so we don’t track its dips. It’s 42% below its 52-week high.
Outside our quality screen, trading well below our fair value estimate, 16% under its Market Value.
Worth knowing
- Deepest drop from a 52-week high in over 3 years
- Down 43% from its 52-week high while revenue grew 21%
From the data on this page, as of the last close. How we pick these
- Fair value est.
- $78.47+46%
- Market Value
- $63.95price −16%
- Off 52-wk high
- −42%
- Risk vs market
- Above marketbeta 1.22
5 bullish · 4 bearish See why
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
How the range is computed
Financials model (residual income). Same residual-income model as the base: cost of equity 9.5% ±1 point and return on equity 19.1% ±2 points. Bear = 10.5% and 17.1%; bull = 8.5% and 21.1%. A model estimate from public filings, not a forecast of where the price will go.
Price sits inside the range.
What the price implies To be worth today’s price, SNEX would need a return on equity of about 16% a year; our estimate uses 19%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much SNEX moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Swings more than the market, and its own price swings are 3.6× the S&P 500’s.
- Beta vs S&P 500
- 1.22
- Volatility
- 47% vs 13% SPY
- Correlation SPY
- 0.34
- Correlation QQQ
- 0.31
How it ranks
Where SNEX stands vs every one of the 1,996 stocks we cover that has the number. Longer bar = better.
Top quarter on 2 of 3 measures
- Discount to fair value estimate46% · price below our base caseTop 23%of 1,314
- Dividends + buybacks yield0% · cash paid out or used to retire shares, vs market capLowest 1%of 1,836
- Revenue growth, last 12 months+21% · vs the 12 months beforeTop 25%of 1,814
From SEC filings and our fair value estimate model. A ranking, not advice.
Valuation details
DCF $78.47 · MV $63.95
Financials model (residual income): book value $23.90 a share on Jun 30, 2026, plus the earnings above a 9.5% cost of equity. ROE 19.1%, the average of 21.6% for the trailing 12 months to Jun 30, 2026 and 16.6% over fiscal 2021–2025, on average common equity; payout 0% of earnings (dividends 0%), so book grows by the retained rest; the return above 9.5% fades halfway toward 9.5% over 10 years, then grows at 3% (terminal value). From the 10-Q filed Aug 5, 2026.
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 5 of 5
ValuationOur residual-income fair value estimate is $78.47, 46% above the price.
GrowthSales compounded 26% a year from FY2022 to FY2025.
GrowthSales grew 21% to $158B over the last 12 months vs the 12 months before (SEC filings).
ProfitabilityReturn on equity of 22% over the last 12 months.
ValuationTrades 15.7% below its Market Value of $63.95, the average price paid since the Aug 5 filing.
Top bearish points 4 of 5
Cash returnsShare count up 10.8% in a year: existing holders are being diluted.
ProfitabilityNet margin of 0.3%, below the 22% median for the 281 Finance companies we cover.
ValuationPrice / book of 2.3×, above the 1.7× median for the 296 Finance companies we cover.
GrowthDiluted EPS grew 11% in the last fiscal year, below the 16% median for the 262 Finance companies we cover.
All fundamentals
P/E 12.3 · ROE 22% · Sales +21%
Valuation
- P/E
- 12.3×Finance median 13.6×
- Price / FCF
- n/acash flow isn't a clean measure for a lender
- FCF yield
- n/acash flow isn't a clean measure for a lender
- EV / EBITDA
- n/anot meaningful for a lender
- Price / sales
- 0.04×
- Price / book
- 2.29×
- Market cap
- $6.5Bprice × diluted shares
- Enterprise value
- n/anot reported in its SEC filings
Growth
- Revenue, 12 months
- $158B
- Sales growth, 12 months
- +20.6%vs the 12 months before
- Sales growth, 3 yrs
- +26.1%/yrfrom FY2022
- Diluted EPS, 12 months
- $7.46
- EPS growth, last FY
- +10.9%
- Net income, 12 months
- $527M
- Net income growth
- +77%12 months vs before
Profitability
- Gross margin
- n/anot meaningful for a lender
- Operating margin
- n/anot reported in its SEC filings
- Net margin
- 0.3%
- FCF margin
- 2.4%
- Return on equity
- 22%
- Return on invested capital
- n/anot meaningful for a lender
Balance sheet
- Cash & short-term inv.
- $2.2B
- Total debt
- n/anot reported in its SEC filings
- Net cash
- n/anot meaningful for a lender
- Debt / equity
- n/adeposits/float make debt/equity not comparable for a lender
- Interest coverage
- n/anot meaningful for a lender
Cash flow & returns
- Free cash flow, 12 months
- $3.8B
- FCF growth, 12 months
- +282%
- Dividend yield
- 0%
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- +10.8%diluted shares vs a year ago
- Stock-based comp
- $56M
Trailing 12 months to Jun 30, 2026; balance sheet at Jun 30, 2026. From StoneX Group’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $3.8B · Sales +15%
- Free cash flow, 12 months$3.8B
- Free-cash-flow yield58.2%
- Return on equity22%
- Sales growth (latest quarter vs year-ago quarter)+15%
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $53.91
- 52-wk lowlowest close, 1 year$37.20−31.0%
- PriceMon Nov 2 close$53.91you are here
- Market Valueavg paid since Aug 5$63.95+18.6%
- Fair value est.base case$78.47+45.6%
- 52-wk highhighest close, 1 year$92.67+71.9%
Momentum & 52-week range
RSI 29 · 5 days −3.3%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Next report
Nov 23
- DateMon Nov 23
- Consensus EPS$0.86
- Year-ago EPS$0.70
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
SNEX is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on StoneX Group in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 1:01 PM ET.
Compare with peers
Closest in size in Brokers & investment banks
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.